Fresenius SE & Co. KGaA buy DirectorDealer_Intensive
Summary
This prediction ended on 15.05.19 with a price of €49.00. With a performance of -8.15%, the BUY prediction for Fresenius SE & Co. KGaA by DirectorDealer_Intensive closed slightly in the red. DirectorDealer_Intensive has 50% into this predictionFresenius is a German healthcare company listed on the Frankfurt and New York stock exchanges under the symbol FSNUF. The company is primarily engaged in the production and distribution of medical devices, pharmaceuticals, and services related to renal dialysis, critical care, and hospital operations. With over 290,000 employees and operations in more than 100 countries, Fresenius is one of the largest healthcare providers in the world. The company has experienced steady growth over the years, driven by its innovative product portfolio, strategic acquisitions, and a focus on operational efficiency.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Fresenius SE & Co. KGaA | 2.332% | 2.332% | 12.071% | -27.714% |
iShares Core DAX® | -0.621% | 1.080% | 11.291% | 16.439% |
iShares Nasdaq 100 | -4.503% | -5.432% | 22.172% | 39.304% |
iShares Nikkei 225® | -2.562% | -1.617% | 7.262% | 8.383% |
iShares S&P 500 | -1.706% | -1.223% | 22.550% | 40.997% |
Comments by DirectorDealer_Intensive for this prediction
In the thread Fresenius SE & Co. KGaA diskutieren
Director's Dealing: Buy
Director's Dealing / Insider Kauf von Bock, Dr. Kurt (Aufsichtsrat)
- Handelstag: 09.11.18
- Volumen: 108240 €
- Meldender: Bock, Dr. Kurt
sharewise.com analyzes all insider trades. Together with the University of Innsbruck we have developed a trading strategy based on intensive trading. Additional information can be found in DirectorDealer_Intensive's profile.